Submissions from 2020
Clinical Mortality in a Large COVID-19 Cohort: Observational Study., M. Jarrett, S. Schultz, J. Lyall, J. Wang, L. Stier, M. De Geronimo, and K. Nelson
Submissions from 2016
Increased pretreatment serum IFN-beta/alpha ratio predicts non-response to tumour necrosis factor alpha inhibition in rheumatoid arthritis, T. Wampler Muskardin, P. Vashisht, J. M. Dorschner, M. A. Jensen, B. S. Chrabot, M. Kern, J. R. Curtis, R. Furie, P. K. Gregersen, T. B. Niewold, and +14 additional authors
Submissions from 2015
Methods for reducing sepsis mortality in emergency departments and inpatient units, M. E. Doerfler, J. D'Angelo, D. Jacobsen, M. P. Jarrett, A. I. Kabcenell, K. D. Masick, D. Parmentier, K. L. Nelson, and L. Stier
Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis, R. Furie, K. Toder, and E. Zapantis
Submissions from 2014
Dose-escalation of human anti-interferon-alpha receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study, A. Goldberg, T. Geppert, E. Schiopu, T. Frech, V. Hsu, R. W. Simms, S. L. Peng, Y. H. Yao, N. Elgeioushi, S. Yoo, and +2 additional authors
A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort, R. L. Gross, J. S. Schwartzman-Morris, M. Krathen, G. Reed, H. Chang, K. C. Saunders, M. C. Fisher, J. D. Greenberg, C. Putterman, A. Broder, and +3 additional authors
Development of Pulmonary Hypertension in a High-risk Population with Systemic Sclerosis in the Pulmonary Hypertension Assessment and RAecognition of Outcomes in Scleroderma (PHAROS) Cohort Study, V M. Hsu, L Chung, L K. Hummers, F Wigley, R Simms, M Bolster, R Silver, A Fischer, A Z. Goldberg, V D. Steen, and +13 additional authors
Rheumatoid myositis leading to acute lower extremity compartment syndrome: a case-based review, D. Jo, T. Pompa, A. Khalil, F. Kong, R. Wetz, and M. Goldstein
A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult- onset Still's disease: targeting IL-6, S. Kadavath, E. Zapantis, R. Zolty, and P. Efthimiou